1998

• PRISMS. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group. Lancet. 1998 Nov 7;352(9139):1498-504.
• betaferon for cpms. Placebo-controlled multicentre randomised trial of interferon beta-1b in treatment of secondary progressive multiple sclerosis. European Study Group on interferon beta-1b in secondary progressive MS. Lancet. 1998 Nov 7;352(9139):1491-7.
• Seasonal variation of interferon-gamma production in progressive ms
• Copaxone maintains its clinical effect on multiple sclerosis relapse
• Ivig treatment in ms

1997

• Impact of interferon beta-1a on disability in rr MS
• Mitoxantrone for active MS, Edan G
• Oral vs iv methylprednisolone for relapses
• 4-aminopyridine for symptomatic treatment of MS
• Influenza vaccinations safe for rrMS
• IvIG for rrMS, further analysis

1996

• Measles Vaccination Has Had No Effect on the Occurrence of MS
• Placebo effect
• EDSS vs Scripps
• Rep, 1996
• Ebers, 1996
• Haines
• Sawcer
• Bell
• Kuokkanen
• Waisman, 1996
• Teitelbaum, 1996
• Rieckmann, 1996
• Beutler E, et al.; The treatment of cpms with cladribine
• Sipe JC, et al.; Cladribine in treatment of cpms

1995

• Methotrexate in cp MS
• Interferon beta-1a for rr MS
• CSHSD Bibliography
• Copolymer I study
• The small heat-shock protein alpha B-crystallin as candidate autoantigen in multiple sclerosis Nature 375: 798-801 (1995). OMIM says 123590
• tau interferon.
• ivmp for ppms
• Progesterone shows potential for treating Multiple Sclerosis, Science 268: 1500-1503 (1995).
• JOURNAL OF NEUROIMMUNOLOGY, Volume 56-63, Issue 971 Supplement 1

Older

• Interferon beta-1b in rr MS
• Cop 1 in cp MS
• Cyclosporine in cp ms